Browse Discover Builder Rankings Pricing

Private market intelligence for investors, founders, and sales teams.

Product

Browse
Discover
List Builder
Rankings
Pricing

Developers

API Reference
API Keys

Company

About
Terms
Privacy
Contact

© 2026 Indexed.vc. All rights reserved.

Arkley BioTek, LLC: Company Profile & Funding | Indexed.vc

Arkley BioTek, LLC

IndyWeb Site

Medical Diagnostics

Headquarters: Indianapolis, Indiana
Employees: 1–10
Founded: 2015

Business Model: B2G
Website: arkleybiotek.com
Total Funding: $1.6M

About

Arkley BioTek is developing blood-based diagnostics for the early detection of Alzheimer's disease. The company is leveraging redox-reactive autoantibodies (R-RAA) as an early, non-invasive serum biomarker for Alzheimer's disease in patients suffering from Mild Cognitive Impairment, enabling detection before significant neurodegeneration occurs.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

No funding data available yet.

Know something? Help us improve our data.

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech

Private Equity·$2.3B·Feb 2020

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech

Private Equity·$2.3B·Aug 2021

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Sydney, Australia1001–5000Biotech, Healthcare

Growth Equity·$1.9B·Mar 2025

Celerion (H.I.G. Capital)

Global clinical research organization specializing in early-stage clinical trials and bioanalytic...

Lincoln, United States501–1000Biotech, Healthcare

Private Equity·$1.8B·Apr 2026

Healthcare company applying technology to drug development by building nimble biotech subsidiarie...

New York, United States501–1000Biotech, Healthcare

Growth Equity·$1.3B·Nov 2018

Neuralink is building a brain-computer interface for medical needs and greater human potential.

Fremont, United States201–500Biotech, Healthcare

Series E·$1.2B·Jun 2025